Brigitte Llanas

1.5k total citations
40 papers, 945 citations indexed

About

Brigitte Llanas is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Brigitte Llanas has authored 40 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Brigitte Llanas's work include Renal Diseases and Glomerulopathies (5 papers), Kidney Stones and Urolithiasis Treatments (4 papers) and Pediatric Urology and Nephrology Studies (4 papers). Brigitte Llanas is often cited by papers focused on Renal Diseases and Glomerulopathies (5 papers), Kidney Stones and Urolithiasis Treatments (4 papers) and Pediatric Urology and Nephrology Studies (4 papers). Brigitte Llanas collaborates with scholars based in France, Netherlands and Réunion. Brigitte Llanas's co-authors include Patrick Niaudet, Michaël Fayon, Hubert Nivet, Thierry Lamireau, Jérôme Harambat, Rémi Salomon, Sophie Taque, Vincent Guigonis, A Bensman and Allison Kennedy and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Brigitte Llanas

39 papers receiving 906 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brigitte Llanas France 15 279 271 212 211 136 40 945
Pekka Arikoski Finland 18 289 1.0× 351 1.3× 117 0.6× 65 0.3× 258 1.9× 44 1.1k
Joseph Giangiacomo United States 16 310 1.1× 194 0.7× 133 0.6× 165 0.8× 103 0.8× 39 1.0k
Kenneth V. Lieberman United States 15 485 1.7× 120 0.4× 128 0.6× 93 0.4× 90 0.7× 38 989
T. Messiaen Belgium 16 202 0.7× 217 0.8× 199 0.9× 68 0.3× 56 0.4× 29 739
Caroline Jones United Kingdom 16 303 1.1× 125 0.5× 161 0.8× 66 0.3× 102 0.8× 37 685
K.N. Lai Hong Kong 20 451 1.6× 162 0.6× 165 0.8× 130 0.6× 29 0.2× 34 982
Warren E. Grupe United States 19 418 1.5× 172 0.6× 147 0.7× 155 0.7× 196 1.4× 53 925
Shane Roy United States 18 373 1.3× 523 1.9× 209 1.0× 142 0.7× 383 2.8× 45 1.0k
M. S. Seshadri India 21 149 0.5× 89 0.3× 145 0.7× 209 1.0× 40 0.3× 71 1.1k
Carmine Pecoraro Italy 19 510 1.8× 181 0.7× 165 0.8× 40 0.2× 113 0.8× 46 969

Countries citing papers authored by Brigitte Llanas

Since Specialization
Citations

This map shows the geographic impact of Brigitte Llanas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Llanas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Llanas more than expected).

Fields of papers citing papers by Brigitte Llanas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitte Llanas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Llanas. The network helps show where Brigitte Llanas may publish in the future.

Co-authorship network of co-authors of Brigitte Llanas

This figure shows the co-authorship network connecting the top 25 collaborators of Brigitte Llanas. A scholar is included among the top collaborators of Brigitte Llanas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitte Llanas. Brigitte Llanas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blouin, Jean‐Marc, Magalie Lalanne, Lamia Azzi‐Martin, et al.. (2019). Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technology. Biochemical and Biophysical Research Communications. 517(4). 677–683. 22 indexed citations
2.
Harambat, Jérôme, et al.. (2017). Conduite à tenir devant un rein unique. Archives de Pédiatrie. 24(11). 1158–1163. 9 indexed citations
3.
Servais, Aude, Cyril Goizet, Aurélia Bertholet‐Thomas, et al.. (2015). La cystinose chez l’adulte : une maladie systémique. Néphrologie & Thérapeutique. 11(3). 152–159. 6 indexed citations
4.
Pereyre, Sabine, et al.. (2013). Hemolytic uremic syndrome complicating Mycoplasma pneumoniae infection. Pediatric Nephrology. 28(10). 2057–2060. 9 indexed citations
5.
Tellier, Stéphanie, Karine Brochard, Arnaud Garnier, et al.. (2013). Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome. Pediatric Nephrology. 28(6). 911–918. 36 indexed citations
6.
Rigothier, Claire, et al.. (2011). Syndrome néphrotique idiopathique de l’enfant : incidence, présentation clinique et devenir dans le département de la Gironde, France. Archives de Pédiatrie. 18(5). 522–528. 9 indexed citations
7.
Joussain, Charles, Delphine Lamireau, Caroline Espil‐Taris, et al.. (2011). A 10-year-old boy with dark urine and acute kidney injury: question. Pediatric Nephrology. 26(8). 1229–1230. 2 indexed citations
8.
Harambat, Jérôme, S. Bui, Fabienne Nacka, et al.. (2010). Renal impairment in children with cystic fibrosis. Journal of Cystic Fibrosis. 9(4). 263–268. 12 indexed citations
9.
Fargue, Sonia, Jérôme Harambat, Marie‐France Gagnadoux, et al.. (2009). Effect of conservative treatment on the renal outcome of children with primary hyperoxaluria type 1. Kidney International. 76(7). 767–773. 51 indexed citations
10.
Dobremez, E., et al.. (2008). Indications et résultats des injections intradétrusoriennes de toxine botulique type A chez l’enfant. Progrès en Urologie. 18(3). 168–171. 6 indexed citations
11.
Guigonis, Vincent, Véronique Baudouin, Maud Dehennault, et al.. (2008). Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatric Nephrology. 23(8). 1269–1279. 186 indexed citations
12.
Tory, Kálmán, Lydie Bürglen, Nathalie Boddaert, et al.. (2007). High NPHP1 and NPHP6 Mutation Rate in Patients with Joubert Syndrome and Nephronophthisis. Journal of the American Society of Nephrology. 18(5). 1566–1575. 112 indexed citations
13.
Willems, Marjolaine, Élie Haddad, Patrick Niaudet, et al.. (2006). Rituximab therapy for childhood-onset systemic lupus erythematosus. The Journal of Pediatrics. 148(5). 623–627.e3. 97 indexed citations
14.
Dobremez, E., Brigitte Llanas, Luke Harper, & J M Bondonny. (2006). The Parapelvic Renal Cyst. A Rare Aetiology of Blood Hypertension in Children. European Journal of Pediatric Surgery. 16(1). 61–63. 2 indexed citations
15.
Lamireau, Thierry, et al.. (2002). Epidemiology of poisoning in children: a 7-year survey in a paediatric emergency care unit. European Journal of Emergency Medicine. 9(1). 9–14. 97 indexed citations
16.
Llanas, Brigitte, et al.. (1999). Malaises graves du nourrisson et de l’enfant. MTP. Médecine thérapeutique pédiatrie. 2(5). 359–368. 1 indexed citations
17.
Fayon, Michaël, et al.. (1998). Pneumopathies communautaires graves chez l'enfant non immunodéprimé. Archives de Pédiatrie. 5. 49s–56s. 1 indexed citations
18.
Lamireau, Thierry, et al.. (1997). Gravité des ingestions de produits caustiques chez l'enfant. Archives de Pédiatrie. 4(6). 529–534. 23 indexed citations
19.
Lamireau, Thierry, Brigitte Llanas, Jean‐François Chateil, et al.. (1996). Fréquence accrue et difficultés diagnostiques des sténoses intestinales après entérocolite ulcéronécrosante. Archives de Pédiatrie. 3(1). 9–15. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026